Axogen [AXGN] vs Establishment Labs [ESTA] Detailed Stock Comparison

Axogen Inc.

NASDAQ
Loading...

Establishment Labs Holdings Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Axogen Inc. wins in 14 metrics, Establishment Labs Holdings Inc. wins in 5 metrics, with 0 ties. Axogen Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Axogen Inc. Establishment Labs Holdings Inc. Better
P/E Ratio (TTM) -110.18 -37.89 Establishment Labs Holdings Inc.
Price-to-Book Ratio 13.15 79.68 Axogen Inc.
Debt-to-Equity Ratio 55.50 1,123.15 Axogen Inc.
PEG Ratio 0.04 0.41 Axogen Inc.
EV/EBITDA -2,165.44 -70.21 Establishment Labs Holdings Inc.
Profit Margin (TTM) -6.97% -24.19% Axogen Inc.
Operating Margin (TTM) -16.31% -6.08% Establishment Labs Holdings Inc.
Return on Equity -13.49% -133.25% Axogen Inc.
Return on Assets (TTM) -2.31% -6.93% Axogen Inc.
Free Cash Flow (TTM) $-4.78M $-57.61M Axogen Inc.
1-Year Return 341.03% 119.39% Axogen Inc.
Price-to-Sales Ratio (TTM) 8.27 8.92 Axogen Inc.
Enterprise Value $1.89B $2.07B Establishment Labs Holdings Inc.
EV/Revenue Ratio 8.40 9.79 Axogen Inc.
Gross Profit Margin (TTM) 74.13% 70.46% Axogen Inc.
Revenue per Share (TTM) $5 $7 Establishment Labs Holdings Inc.
Earnings per Share (Diluted) $-0.34 $-1.72 Axogen Inc.
Beta (Stock Volatility) 0.98 1.08 Axogen Inc.
Short % of Float 6.92% 22.26% Axogen Inc.

Axogen Inc. vs Establishment Labs Holdings Inc. Stock Performance Analysis

Loading Price Chart...

AXGN
ESTA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Axogen Inc.1.72%5.50%6.71%33.19%46.88%41.10%
Establishment Labs Holdings Inc.2.52%12.52%28.06%32.66%16.91%22.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Axogen Inc.341.03%367.90%106.53%628.81%1,769.57%12,185.71%
Establishment Labs Holdings Inc.119.39%25.90%5.07%211.25%211.25%211.25%

Performance & Financial Health Analysis: Axogen Inc. vs Establishment Labs Holdings Inc.

MetricAXGNESTA
Market Information
Market Cap i$1.94B$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,245,238451,437
90 Day Avg. Volume i1,068,353478,309
Last Close$43.74$84.21
52 Week Range$9.22 - $45.83$33.35 - $86.00
% from 52W High-4.56%-2.08%
All-Time High$56.85 (Jul 23, 2018)$93.80 (Apr 18, 2022)
% from All-Time High-23.06%-10.22%
Growth Metrics
Quarterly Revenue Growth0.21%0.45%
Quarterly Earnings Growth0.21%0.45%
Financial Health
Profit Margin (TTM) i-0.07%-0.24%
Operating Margin (TTM) i-0.16%-0.06%
Return on Equity (TTM) i-0.13%-1.33%
Debt to Equity (MRQ) i55.501,123.15
Cash & Liquidity
Book Value per Share (MRQ)$2.73$0.80
Cash per Share (MRQ)$0.80$2.58
Operating Cash Flow (TTM) i$812,000$-50,890,000
Levered Free Cash Flow (TTM) i$3.58M$-41,574,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Axogen Inc. vs Establishment Labs Holdings Inc.

MetricAXGN (Apr 24, 2026)ESTA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-110.18-37.89
Forward P/E i47.31316.35
PEG Ratio i0.040.41
Price to Sales (TTM) i8.278.92
Price to Book (MRQ) i13.1579.68
Market Capitalization
Market Capitalization i$1.94B$1.91B
Enterprise Value i$1.89B$2.07B
Enterprise Value Metrics
Enterprise to Revenue i8.409.79
Enterprise to EBITDA i-2,165.44-70.21
Risk & Other Metrics
Beta i0.981.08
Book Value per Share (MRQ) i$2.73$0.80

Financial Statements Comparison: Axogen Inc. vs Establishment Labs Holdings Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAXGN (2025)ESTA (2025)
Revenue/Sales i225.21M211.08M
Cost of Goods Sold i57.86M64.77M
COGS % of Revenue i25.7%30.7%
Gross Profit i167.35M146.31M
Gross Margin i74.3%69.3%
Research & Development i32.89M20.25M
Operating Income (EBIT) i-7.85M-39.01M
Operating Margin i-3.5%-18.5%
EBITDA i826,000-22.29M
EBITDA Margin i0.4%-10.6%
Pre-Tax Income i-15.70M-58.02M
Pre-Tax Income % of Revenue i-7.0%-27.5%
Income Tax iN/A-6.96M
Income Tax % of Revenue i0.0%-3.3%
Net Income (Profit) i-15.70M-51.06M
Profit Margin i-7.0%-24.2%

Balance Sheet & Liquidity Metrics

MetricAXGN (2025)ESTA (2025)
Cash & Equivalents i35.55M75.57M
Total Current Assets i120.42M249.94M
Total Current Assets % of Revenue i53.5%118.4%
Total Current Liabilities i23.56M82.14M
Total Current Liabilities % of Revenue i10.5%38.9%
Long-Term Debt i65.26M250.34M
Long-Term Debt % of Revenue i29.0%118.6%
Total Shareholders Equity i128.85M23.55M
Retained Earnings i-306.96M-495.76M
Retained Earnings % of Revenue i-136.3%-234.9%
Property, Plant & Equipment i29.38M4.34M

Cash Flow Statement Comparison

MetricAXGN (2025)ESTA (2025)
Operating Cash Flow i10.26M-50.78M
Operating Cash Flow % of Revenue i4.6%-24.1%
Capital Expenditures i-3.75M-6.05M
Free Cash Flow i-4.78M-57.61M
FCF Margin i-2.1%-27.3%
Debt Repayment i-32,000-1.02M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAXGNESTA
Shares Short i3.50M5.22M
Short Ratio i4.049.90
Short % of Float i6.92%22.26%
Shares Outstanding i47.20M29.30M
Float Shares i50.75M19.22M
% Held by Insiders i2.12%10.16%
% Held by Institutions i88.11%102.08%
% Held by Public i9.77%-12.24%

Dividend Analysis & Yield Comparison: Axogen Inc. vs Establishment Labs Holdings Inc.

MetricAXGNESTA
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A